Ibsa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IBSA
IBSA has six approved drugs.
There are seven US patents protecting IBSA drugs.
There are thirty patent family members on IBSA drugs in thirteen countries and four supplementary protection certificates in four countries.
Summary for Ibsa
| International Patents: | 30 |
| US Patents: | 7 |
| Tradenames: | 6 |
| Ingredients: | 4 |
| NDAs: | 6 |
| Patent Litigation for Ibsa: | See patent lawsuits for Ibsa |
Drugs and US Patents for Ibsa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-014 | Jan 13, 2021 | RX | Yes | No | 11,096,913 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-006 | Dec 15, 2016 | RX | Yes | No | 11,241,382 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-009 | Oct 2, 2009 | RX | Yes | No | 12,564,565 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ibsa Inst Bio | LICART | diclofenac epolamine | SYSTEM;TOPICAL | 206976-001 | Dec 19, 2018 | RX | Yes | Yes | 11,351,133 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ibsa | VYBRIQUE | sildenafil citrate | FILM;ORAL | 210858-004 | Dec 16, 2025 | RX | Yes | Yes | 11,123,287 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ibsa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | 4,948,805 | ⤷ Start Trial |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-004 | Oct 13, 2006 | 7,691,411 | ⤷ Start Trial |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-002 | Oct 13, 2006 | 7,691,411 | ⤷ Start Trial |
| Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | 5,607,690 | ⤷ Start Trial |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-011 | Apr 25, 2017 | 7,691,411 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for IBSA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Patch | 1.3% | ➤ Subscribe | 2015-06-26 |
International Patents for Ibsa Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 2900215 | ⤷ Start Trial |
| Russian Federation | 2019106889 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2020178074 | ⤷ Start Trial |
| Hungary | E036324 | ⤷ Start Trial |
| Denmark | 3930703 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ibsa Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0463756 | SPC/GB99/004 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: SILDENAFIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR THE CITRATE SALT; REGISTERED: CH 54642 19980622; UK EU/1/98/077/001 19980914; UK EU/1/98/077/002 19980914; UK EU/1/98/077/003 19980914; UK EU/1/98/077/004 19980914; UK EU/1/98/077/005 19980914; UK EU/1/98/077/006 19980914; UK EU/1/98/077/007 19980914; UK EU/1/98/077/008 19980914; UK EU/1/98/077/009 19980914; UK EU/1/98/077/010 19980914; UK EU/1/98/077/011 19980914; UK EU/1/98/077/012 19980914 |
| 0463756 | C990005 | Netherlands | ⤷ Start Trial | PRODUCT NAME: SILDENAFIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT, IN HET BIJZONDER SILDENAFIL CITRAAT; NATL REGISTRATION NO/DATE: EU/1/98/077/001-012 19980914; FIRST REGISTRATION: CH 54642 19980622 |
| 0463756 | 5/1999 | Austria | ⤷ Start Trial | PRODUCT NAME: ''SILDENAFIL'' UND DESSEN PHARMAZEUTISCH ANNEHMBAREN SALZE, EINSCHLIESSLICH DES CITRATS; NAT. REGISTRATION NO/DATE: EU/1/98/077/001 - EU/1/98/077/012 19980914; FIRST REGISTRATION: LI 54642 01-54642 03 19980622 |
| 0463756 | 99C0007 | Belgium | ⤷ Start Trial | PRODUCT NAME: SILDENAFIL, NATL REGISTRATION NO/DATE: EU/1/98/077/001 19980914; FIRST REGISTRATION: CH 54642 19980622 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
